Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lett Appl Microbiol ; 75(4): 844-856, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-35575477

RESUMO

Butyrate-producing bacteria generate butyrate, which has antidepressant effects. Xiaoyaosan (XYS), a traditional Chinese medicine (TCM) used to treat depression, may improve depression-like behaviour by modulating the gut microbiota. However, the functional groups and mechanisms of action in the XYS treatment of depression remain unknown. This study aimed to analyse with clone sequencing the changes in intestinal butyrate-producing bacteria in XYS-treated chronic unpredictable mild stress (CUMS) rats. We successfully established the XYS-treated CUMS rat model of depression. Rat faecal samples were collected before, during, and after the experiment, and butyryl-CoA:acetate CoA-transferase gene primers were selected for PCR amplification to determine the diversity of butyrate-producing bacteria. The results showed that XYS increased intestinal butyrate-producing bacterial diversity in CUMS rats regarding phylum and genus numbers; the number of phyla increased to two, distributed in Firmicutes and Bacteroides, and four genera were distributed in Eubacterium sp., Roseburia sp., Clostridium sp. and Bacteroides sp. Only one phylum and two genera were present in the model group without XYS treatment. Our findings indicate that XYS can improve depression-like behaviour by regulating intestinal butyrate-producing bacteria diversity, particularly Roseburia sp. and Eubacterium sp., thus providing new insights into the targeted regulation of the intestinal flora to treat depression.


Assuntos
Coenzima A-Transferases , Depressão , Acetatos , Animais , Antidepressivos/farmacologia , Bactérias , Comportamento Animal , Butiratos/farmacologia , Coenzima A-Transferases/farmacologia , Depressão/tratamento farmacológico , Depressão/genética , Depressão/microbiologia , Modelos Animais de Doenças , Medicamentos de Ervas Chinesas , Ratos
2.
Br J Haematol ; 121(6): 928-31, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12786805

RESUMO

ABO blood group determines plasma von Willebrand factor (VWF) levels and ABH antigens are present on VWF. To investigate whether ABO influences the rate of VWF synthesis, we performed stable transfection of A transferase in a phenotypically group-O endothelial cell line (EAhy926). A transferase expression did not affect the rate of VWF synthesis. Although high levels of A antigen were expressed on the cell surface, no A determinants were added to VWF synthesized within these cells. Further studies demonstrated H structures were not present on EAhy926-derived VWF, despite the fact that H antigen is constitutively expressed by these cells.


Assuntos
Sistema ABO de Grupos Sanguíneos/metabolismo , Endotélio Vascular/metabolismo , Fator de von Willebrand/biossíntese , Linhagem Celular , Coenzima A-Transferases/farmacologia , Ensaio de Imunoadsorção Enzimática , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...